Aldara™ Cream, 5% (Imiquimod)
Content:
COMPLIANCE
- Local irritation is the most significant limiting factor.
- Note that irritation of the skin (cytokine-induced dermatitis) is a desired pharmacodynamic response.
- Titrating the frequency of applications is essential for optimal response and better tolerance of the therapy.